IGEM Therapeutics awarded Best Start-up Biotech Company at the UK's OBN Awards
IGEM Therapeutics (London, UK), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer, has won the “Best Start-up Biotech Company” award at the OBN Awards 2018. The award recognizes IGEM as a UK registered start-up biotech company making a significant impact in the sector through news flow, successful fundraising and execution of a robust business plan. The ceremony on Thursday October 11 marked the 10th anniversary of the OBN Awards, which celebrate success stories from the UK life sciences industry over the past year. Dr. Tim Wilson, Chief Executive Officer of IGEM, commented: “We are thrilled that IGEM Therapeutics has been awarded “Best Start-up Biotech Company” at this year’s prestigious OBN Awards. The award recognizes our efforts to treat cancer by developing novel immunoglobin E antibodies and our significant progress as a company over the last year.”
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
